GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 07, 2023, titled "Media release: Q3 of 2022-23".
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 07, 2023, titled "Media release: Q3 of 2022-23".